SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    E. Jason Abel, Tyler M. Bauman, Madelyn Weiker, Fangfang Shi, Tracy M. Downs, David F. Jarrard, Wei Huang, Analysis and validation of tissue biomarkers for renal cell carcinoma using automated high-throughput evaluation of protein expression, Human Pathology, 2014, 45, 5, 1092

    CrossRef

  2. 2
    Tin C. Ngo, Christopher G. Wood, Jose A. Karam, Biomarkers of renal cell carcinoma, Urologic Oncology: Seminars and Original Investigations, 2014, 32, 3, 243

    CrossRef

  3. 3
    Daniel de Oliveira, Marcos F. Dall’Oglio, Sabrina T. Reis, Marcelo Zerati, Isida C. Souza, Katia R. Leite, Miguel Srougi, Chromosome 9p deletions are an independent predictor of tumor progression following nephrectomy in patients with localized clear cell renal cell carcinoma, Urologic Oncology: Seminars and Original Investigations, 2014,

    CrossRef

  4. 4
    J Sanjmyatav, S Matthes, M Muehr, D Sava, M Sternal, H Wunderlich, M Gajda, M-O Grimm, K Junker, Identification of high-risk patients with clear cell renal cell carcinoma based on interphase-FISH, British Journal of Cancer, 2014,

    CrossRef

  5. 5
    Gino Marioni, Stella Blandamura, Marco Lionello, Luciano Giacomelli, Andrea Lovato, Niccolò Favaretto, Stefano Breda, Giulia Tealdo, Vincenza Guzzardo, Giancarlo Ottaviano, Alberto Staffieri, Indications for postoperative radiotherapy in laryngeal carcinoma: A panel of tumor tissue markers for predicting locoregional recurrence in surgically treated carcinoma. A pilot study, Head & Neck, 2014, 36, 5
  6. 6
    Bishoy A. Gayed, Ramy F. Youssef, Aditya Bagrodia, Oussama M. Darwish, Payal Kapur, Arthur Sagalowsky, Yair Lotan, Vitaly Margulis, Ki67 is an independent predictor of oncological outcomes in patients with localized clear-cell renal cell carcinoma, BJU International, 2014, 113, 4
  7. 7
    Richard W. Joseph, Payal Kapur, Daniel J. Serie, Jeanette E. Eckel-Passow, Mansi Parasramka, Thai Ho, John C. Cheville, Eugene Frenkel, Dinesh Rakheja, James Brugarolas, Alexander Parker, Loss of BAP1 protein expression is an independent marker of poor prognosis in patients with low-risk clear cell renal cell carcinoma, Cancer, 2014, 120, 7
  8. 8
    A. Hartmann, T. Schlomm, S. Bertz, J. Heinzelmann, S. Hölters, R. Simon, R. Stoehr, K. Junker, Prognostische und prädiktive molekulare Marker urologischer Tumoren, Der Urologe, 2014, 53, 4, 491

    CrossRef

  9. 9
    Ben Y. Zhang, R. Houston Thompson, Christine M. Lohse, Roxana S. Dronca, John C. Cheville, Eugene D. Kwon, Bradley C. Leibovich, Carbonic anhydrase IX (CAIX) is not an independent predictor of outcome in patients with clear cell renal cell carcinoma (ccRCC) after long-term follow-up, BJU International, 2013, 111, 7
  10. 10
    George J. Netto, Clinical Applications of Recent Molecular Advances in Urologic Malignancies, Advances In Anatomic Pathology, 2013, 20, 3, 175

    CrossRef

  11. 11
    Oussama M. Darwish, Payal Kapur, Ramy F. Youssef, Aditya Bagrodia, Michael Belsante, Feras Alhalabi, Arthur I. Sagalowsky, Yair Lotan, Vitaly Margulis, Cumulative Number of Altered Biomarkers in Mammalian Target of Rapamycin Pathway Is an Independent Predictor of Outcome in Patients With Clear Cell Renal Cell Carcinoma, Urology, 2013, 81, 3, 581

    CrossRef

  12. 12
    Laura-Maria Krabbe, Mary E. Westerman, Aditya Bagrodia, Bishoy A. Gayed, Oussama M. Darwish, Ahmed Q. Haddad, Dina Khalil, Payal Kapur, Arthur I. Sagalowsky, Yair Lotan, Vitaly Margulis, Dysregulation of β-Catenin Is an Independent Predictor of Oncological Outcomes in Patients with Clear Cell Renal Cell Carcinoma, The Journal of Urology, 2013,

    CrossRef

  13. 13
    Charlotte Domblides, Marine Gross-Goupil, Amandine Quivy, Alain Ravaud, Emerging antiangiogenics for renal cancer, Expert Opinion on Emerging Drugs, 2013, 18, 4, 495

    CrossRef

  14. 14
    Alexander S. Parker, Jeanette E. Eckel-Passow, Daniel Serie, Tracy Hilton, Mansi Parasramka, Richard W. Joseph, Kevin J. Wu, John C. Cheville, Bradley C. Leibovich, Higher Expression of Topoisomerase II Alpha Is an Independent Marker of Increased Risk of Cancer-specific Death in Patients with Clear Cell Renal Cell Carcinoma, European Urology, 2013,

    CrossRef

  15. 15
    Alexandra Bailey, David F. McDermott, Immune Checkpoint Inhibitors as Novel Targets for Renal Cell Carcinoma Therapeutics, The Cancer Journal, 2013, 19, 4, 348

    CrossRef

  16. 16
    Thomas Weber, Matthias Meinhardt, Stefan Zastrow, Andreas Wienke, Susanne Fuessel, Manfred P. Wirth, Immunohistochemical Analysis of Prognostic Protein Markers for Primary Localized Clear Cell Renal Cell Carcinoma, Cancer Investigation, 2013, 31, 1, 51

    CrossRef

  17. 17
    Rachel A. Craven, Naveen S. Vasudev, Rosamonde E. Banks, Proteomics and the search for biomarkers for renal cancer, Clinical Biochemistry, 2013, 46, 6, 456

    CrossRef

  18. 18
    Malek Meskawi, Maxine Sun, Quoc-Dien Trinh, Marco Bianchi, Jens Hansen, Zhe Tian, Michael Rink, Salima Ismail, Shahrokh F. Shariat, Francesco Montorsi, Paul Perrotte, Pierre I. Karakiewicz, A Review of Integrated Staging Systems for Renal Cell Carcinoma, European Urology, 2012, 62, 2, 303

    CrossRef

  19. 19
    Brian Hu, Primo N. Lara, Christopher P. Evans, Defining an Individualized Treatment Strategy for Metastatic Renal Cancer, Urologic Clinics of North America, 2012, 39, 2, 233

    CrossRef

  20. 20
    Patrick A. Kenney, Christopher G. Wood, Integration of Surgery and Systemic Therapy for Renal Cell Carcinoma, Urologic Clinics of North America, 2012, 39, 2, 211

    CrossRef

  21. 21
    Lui Shiong Lee, Min-Han Tan, Predictive models for the practical management of renal cell carcinoma, Nature Reviews Urology, 2012, 9, 2, 73

    CrossRef

  22. 22
    Ramy F. Youssef, Nicholas G. Cost, Oussama M. Darwish, Vitaly Margulis, Prognostic markers in renal cell carcinoma: A focus on the ‘mammalian target of rapamycin’ pathway, Arab Journal of Urology, 2012, 10, 2, 110

    CrossRef

  23. 23
    S H Sim, M P Messenger, W M Gregory, T C Wind, N S Vasudev, J Cartledge, D Thompson, P J Selby, R E Banks, Prognostic utility of pre-operative circulating osteopontin, carbonic anhydrase IX and CRP in renal cell carcinoma, British Journal of Cancer, 2012, 107, 7, 1131

    CrossRef

  24. 24
    Michela de Martino, Tobias Klatte, Andrea Haitel, Michael Marberger, Serum cell-free DNA in renal cell carcinoma, Cancer, 2012, 118, 1
  25. 25
    Steven C. Campbell, Brian R. Lane, Campbell-Walsh Urology, 2012,

    CrossRef

  26. 26
    Egbert Oosterwijk, W. Kimryn Rathmell, Kerstin Junker, A. Rose Brannon, Frédéric Pouliot, David S. Finley, Peter F.A. Mulders, Ziya Kirkali, Hirotsugo Uemura, Arie Belldegrun, Basic Research in Kidney Cancer, European Urology, 2011, 60, 4, 622

    CrossRef

  27. 27
    Patricia A. Tang, Michael M. Vickers, Daniel Y.C. Heng, Clinical and Molecular Prognostic Factors in Renal Cell Carcinoma: What We Know So Far, Hematology/Oncology Clinics of North America, 2011, 25, 4, 871

    CrossRef

  28. 28
    Maxine Sun, Shahrokh F. Shariat, Christopher Cheng, Vincenzo Ficarra, Masaru Murai, Stéphane Oudard, Allan J. Pantuck, Richard Zigeuner, Pierre I. Karakiewicz, Prognostic Factors and Predictive Models in Renal Cell Carcinoma: A Contemporary Review, European Urology, 2011, 60, 4, 644

    CrossRef

  29. 29
    Naveen S. Vasudev, Rosamonde E. Banks, Biomarkers in Kidney Disease, 2011,

    CrossRef

  30. 30
    Sabine Brookman-May, Matthias May, Christian Gilfrich, Wolf Ferdinand Wieland, Maximilian Burger, Can vaccination or tyrosine kinase inhibitor therapy play a role in the adjuvant treatment of renal cell carcinoma?, Expert Review of Anticancer Therapy, 2010, 10, 6, 813

    CrossRef

  31. 31
    Maxine Sun, Shahrokh F Shariat, Pierre I Karakiewicz, Factors affecting outcome in renal cell carcinoma, Current Opinion in Urology, 2010, 20, 5, 355

    CrossRef

  32. 32
    Jay B Shah, Vitaly Margulis, In search of a better crystal ball: recent advances in prognostic markers for clear-cell renal cell carcinoma, Expert Review of Anticancer Therapy, 2010, 10, 6, 837

    CrossRef

  33. 33
    Michael M. Vickers, Daniel Y. C. Heng, Prognostic and predictive biomarkers in renal cell carcinoma, Targeted Oncology, 2010, 5, 2, 85

    CrossRef

  34. 34
    A. Rose Brannon, W. Kimryn Rathmell, Renal Cell Carcinoma: Where Will the State-of-the-Art Lead Us?, Current Oncology Reports, 2010, 12, 3, 193

    CrossRef

  35. 35
    Jeremiah J. Morrissey, Amy N. London, Jingqin Luo, Evan D. Kharasch, Urinary Biomarkers for the Early Diagnosis of Kidney Cancer, Mayo Clinic Proceedings, 2010, 85, 5, 413

    CrossRef

  36. 36
    Eric Jonasch, Prognostic models, Cancer, 2009, 115, 10